Aelis Farma
2013
FOUNDED
PRIVATE
STATUS
11-20
EMPLOYEES
Grant
LATEST DEAL TYPE
$9.9M
LATEST DEAL AMOUNT
10
INVESTORS
Description
Developer of signaling specific therapeutics designed for the treatment of cannabis abuse. The company's signaling specific therapeutics specializes in the development of first-in-class CB1 (cannabinoid receptor) signaling specific inhibitors targeting cannabis abuse, enabling physicians to provide proper feedback on treatment progress.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
- Neurocentre Magendie
- 146, rue Léo Saignat
- 33077 Bordeaux
- France
+33 05 00 00 00 00
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Aelis Farma’s full profile, request a free trial.
Aelis Farma Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Grant | 13-Dec-2019 | $9.9M | 00.00 | Completed | Startup | |
| 7. Later Stage VC | 13-Dec-2019 | 00.000 | 00.00 | Completed | Startup | |
| 6. Early Stage VC | 20-Dec-2017 | 00.000 | 00.000 | 000.00 | Completed | Startup |
| 5. Early Stage VC | 11-Jun-2017 | 00000 | 00.000 | 00.000 | Completed | Startup |
| 4. Grant | 07-Oct-2015 | 00000 | 00.00 | Completed | Startup | |
| 3. Grant | 00.000 | 00.00 | Completed | Startup | ||
| 2. Seed Round | 27-Mar-2014 | $2.03M | $2.3M | 00.000 | Completed | Startup |
| 1. Seed Round | 16-Dec-2013 | $272K | $272K | 00000 | Completed | Startup |
Aelis Farma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 00,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | |
| ABSA2014 | 00,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 | |
| Ordinary | 58,000 | $0.011826 | $29.97 | $29.97 | 1x | $29.97 | 19.69% | |
| Ordinary | 50,000 | $0.011826 | $4.73 | $4.73 | 1x | $4.73 | 16.98% |
Aelis Farma Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Aquitaine-Creation-Innovation | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Bpifrance | Sovereign Wealth Fund | Minority | 000 0000 | 000000 0 | ||
| Irdi Soridec Gestion | Asset Manager | Minority | 000 0000 | 000000 0 | ||
| Le Conseil régional d'Aquitaine | Other | Minority | 000 0000 | 000000 0 | ||
| National Angel Capital Organization | Other | Minority | 000 0000 | 000000 0 |
Aelis Farma Executive Team (7)
You’re viewing 5 of 7 executives. Get the full list »Aelis Farma Board Members (5)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Alain Sainsot | Aelis Farma | Board Member | 000 0000 | |
| François Thomas MD | Aelis Farma | Chairman | 000 0000 | |
| Pier Piazza Ph.D | Aelis Farma | Co-Founder, Chief Executive Officer & Board Member | 000 0000 | |
| Thibaut Richebois | Aelis Farma | Board Member | 000 0000 |
1 Former Board Member
You’re viewing 4 of 5 board members. Get the full list »